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Background. Grewia asiatica Linn, or phalsa, is a commonly consumed fruit in Pakistan. The fruit is employed in the traditional
medicine practice of Pakistan as a smooth muscle relaxant in diﬀerent gastrointestinal (GI) and cardiovascular diseases. In this
investigation, we show the antispasmodic and vasorelaxant actions of Grewia asiatica fruit extract. Methods. A 70% methanolic
crude extract of the plant material was prepared (Ga.Cr). Diﬀerent isolated GI tissue preparations and endothelium-intact aortas
from rats were utilized to observe the pharmacological actions of the extract. Results. Ga.Cr, in increasing concentrations,
inhibited the spontaneously contracting rabbit jejunum. In an eﬀort to determine the mechanism of this relaxant action,
contractions were induced in jejunum and ileum tissues with K+ (80 mM). Ga.Cr was able to only partially inhibit these induced
contractions indicating that the mechanism might not be completely through a blockade of Ca2+ channels (CCB). When tested on
low K+-(25 mM) sustained contractions, Ga.Cr cumulatively suppressed these contractions (0.1–10 mg/ml), indicating an opening
of K+ channels (KCO) as the mechanism. Cromakalim, a standard KCO, was also more speciﬁc in blocking low K+-induced
contractions. For the eﬀect in aorta tissues, Ga.Cr suppressed the agonist-induced contractions from 0.3 mg/ml to 10 mg/ml.
Upon challenge with L-NAME, a nitric oxide (NO) blocker, the extract response curve shifted right, indicating vasodilation was
mediated via endothelial NO. Conclusion. This study shows that GI antispasmodic and vasodilator activities of Ga.Cr may be
mediated via a KCO mechanism in the GI tract and through the release of NO from vascular endothelium.

1. Introduction
Grewia asiatica Linn (family Tiliaceae) is a plant commonly
known and cultivated in South Asia. It is known by the
common name of phalsa in Hindi and Urdu. The plant
grows into a small tree or shrub around ﬁve meters in height.
The fruit from the tree, also known as phalsa (purple to black
and 1–1.5 cm in diameter), is an edible berry that is very
popular with the people of South Asia. It is known specifically as a cooling agent in the summer months, and people
typically eat the berry raw or consume as juice or syrup. Not
only is the phalsa fruit liked as an edible berry, but the berry

and other parts of the plant, including the bark, leaves, buds,
and roots, are used by traditional healers of the region for
their medicinal beneﬁt [1]. The bark and roots are known to
relieve inﬂammation of joints and muscles, the leaves are
useful for infectious skin conditions, and the fruit is known
to be beneﬁcial in indigestion, diarrhea, and cardiac/heart
disorders [1–3].
Some of the pharmacological studies performed on the
plant show its medicinal beneﬁts in anxiety, depression,
memory impairment [4], diabetes, hyperlipidemia [5–8],
pain, fever, inﬂammation [7, 9, 10], and infections [11, 12].
In terms of the phytochemical constituents, prior studies
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report that Grewia asiatica has several polyphenols [13, 14],
carbohydrates, tannins, vitamin C [15], and diﬀerent amino
acids [3].
We undertook this project to justify the use of Grewia
asiatica fruit in gastrointestinal (GI) and cardiac disorders.
In the course of our experiments, we found that the 70%
aqueous methanolic extract of Grewia asiatica fruit exhibited
antispasmodic activity in isolated GI tissue preparations and
the vasodilator eﬀect in isolated vascular tissues.

2. Materials and Methods
2.1. Animals. A determined eﬀort was undertaken to
minimize the suﬀering of the animals at every step of this
project. Experiments were performed as detailed in the
European Community guidelines, EEC Directive 86/609/
EEC. Smooth muscle tissues were acquired from local
rabbits weighing around 1 kg and guinea pigs with an average weight of .5 kg of both sexes were used. SpragueDawley rats of either sex, weighing around 200 g, were also
used. These animals were kept in Aga Khan University’s
animal house where the temperature was kept between 23°C
and 25°C, while the conditions were ensured to be pathogenfree. The animals were given water as needed. A standard
diet was provided to the animals [16], though it was withdrawn a day before the experiment.
2.2. Drugs and Reagents. For the experimentation part, the
following standard pharmacological agonists and antagonists were used: acetylcholine chloride (ACh), L-NG-nitro
arginine methyl ester (L-NAME), phenylephrine (PE), potassium chloride, and verapamil (all from Sigma, USA).
Tocris and RBI Chemicals were contacted for cromakalim
and glibenclamide, respectively. For the physiologic salt
solutions, Tyrode’s and Krebs’s solutions were used, the
ingredients of which were acquired from Sigma Chemical
Co. and Merck, Germany.
2.3. Crude Extract Preparation. Around 1 kg of phalsa
berries were collected in Karachi, Sind, Pakistan (geographical coordinates: latitude 24°53′40.3224″N, longitude
67°3′48.906″E (degrees, minutes and seconds, DMS); or Lat
24.894534, Long 67.063585 (decimal degrees, DD)). A
specimen of this was identiﬁed and sampled with the
Herbarium of Department of Biological and Biomedical
Sciences, Aga Khan University.
The phalsa fruit was cleaned, washed, and then lightly
opened up with a pestle. For the process of making an
extract, these were then dipped in a couple of liters of a
mixture of 30% distilled water and 70% methanol (analytical
grade from Merck Co., Darmstadt, Germany) for 72 hours.
At the end of this period, the contents were ﬁltered through a
cloth ﬁlter, and the plant material was again dipped in a new
supply of solvent mixture, twice, for 72 hours each. Finally,
all the ﬁltrates were collected and passed through Whatman
ﬁlter paper. For the process of concentration, a rotary
evaporator was used. This resulted in obtaining a viscous
extract coded as Ga.Cr.
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2.4. Rabbit Jejunum. We have performed this method of
utilizing isolated rabbit jejunum tissues for pharmacological
testing before [16]. To brieﬂy describe the method here,
pieces of intestinal jejunum around 2 cm long were acquired
from rabbits and hung using cotton thread in glass muscle
baths with Tyrode’s at 37°C. Tyrode’s solution was bubbled
with carbogen gas. A preload of a gram was used on jejunum
segments and were left to stabilize for half an hour and
connected to oscillographs and isotonic force transducers
(Harvard Apparatus, USA). The tissues were stabilized with
a standard contractile agent ACh (1 μM). Rabbit jejunum is a
tissue that when set up like this elicits spontaneous rhythmic
contractions that help in testing for both spasmolytic and
spasmogenic agents. The muscle inhibitory eﬀect of the
extract was calculated in comparison to the baseline muscle
contractility, while any possible spasmogenic eﬀect was
compared to the ACh maximum eﬀect.
A potential spasmolytic response from the test extract
was further investigated on contractions sustained in rabbit
jejunum with the help of high K+ (80 mM) and low K+
(25 mM). Suppression of high K+ indicated a calcium
channel blocking (CCB) eﬀect, and suppression of low K+
indicated a relaxant eﬀect mediated via the opening of K+
channels [17, 18]. The suppression of these induced contractions by Ga.Cr was calculated as compared to the eﬀect
exhibited by high and low K+.
2.5. Guinea Pig Ileum. We have described working with the
guinea pig ileum in detail before [19]. In summary, 1-2 cm
long pieces of ileum were obtained from guinea pigs. These
pieces were maintained in tissue baths, and recordings were
made as described above for rabbit jejunum. Tissues were
kept for 30 minutes to normalize and then stabilized with
repeated doses of a standard agent, ACh (1 μM). A threeminute gap was allowed between administered concentrations of standard or test agents. Unlike rabbit jejunum,
guinea pig ileum does not exhibit rhythmic contractions but
only shows a ﬂat baseline ideal for testing of potential
spasmogenic agents. Spasmolytic activity can be tested with
the help of an agonist. This was done the same way as
described with jejunum tissues. Contractions were obtained
with a high strength of K+. Later, the test substance was
administered cumulatively to record for any relaxant
activity.
2.6. Endothelium-Intact Rat Aorta. A previously described
method was followed [20] with some changes [21]. In brief,
aorta tissue was carefully obtained, so that the endothelial
part stayed intact. Tissue of about 3 mm width was maintained at 37°C in Krebs’s and aerated with carbogen gas.
Baseline tension of a gram was used, and rings were left to
normalize for half an hour. Any changes with the vascular
muscle were recorded with the help of isometric force
transducers (World Precision Instruments Fort 100), linked
with Transbridge 4 M and captured through the CVMS data
acquisition system. Standard vasoconstrictor PE (1 μM) was
used for tissue stabilization. While in poststabilization, the
contraction was induced with the same agent. Acetylcholine
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(0.1 μM) was utilized to test endothelial-mediated suppression of PE contractility. Later, the test extract was administered on PE contractions in increased concentrations. For
any potential characterization of a vasodilator eﬀect,
L-NAME (0.1 mM; 60-minute pretreatment period) was
used as an antagonist to block a potential nitric-oxide- (NO-)
mediated vasodilator eﬀect in the endothelium-intact
preparations.
2.7. Representation of Results. The results are expressed as
the mean ± standard error of the mean, or SEM, while “n” is
the number of observations. The median eﬀective concentrations (EC50) have 95% conﬁdence intervals (CI). Curves
were compared utilizing two-way analysis of variance
(ANOVA) with p < 0.05 suggesting meaningful diﬀerence
(GraphPad, USA).

3. Results
3.1. Rabbit Jejunum. Ga.Cr exhibited a spasmolytic eﬀect on
the default spontaneously beating jejunal tissue when used in
increasing concentrations from 0.3 mg/ml to 10 mg/ml. The
EC50 for this eﬀect was 4.4 mg/ml (3.5–5.3, n � 7). The extract concentration of 10 mg/ml completely suppressed the
jejunum contractility (Figure 1). High K+ (80 mM) was
administered to ﬁgure out the reason for this relaxation, and
sustained contractions were obtained. Ga.Cr was then administered cumulatively on these contractions. The extract
from 3 mg/ml to 30 mg/ml only partially suppressed K+
80 mM contractions (Figures 1 and 2). The EC50 for this
eﬀect was 7.1 mg/ml (5.3–9.3, n � 3). In comparison, Ga.Cr
(0.1–10 mg/ml) fully suppressed K+ 25 mM induced contractions with EC50 of 1.6 mg/ml (1.1–2.4, n � 3, Figure 2).
The action of Ga.Cr on 80 mM compared to 25 mM was
signiﬁcantly diﬀerent (p < 0.0001). The depressant action of
the extract on 25 mM was blocked (curve shifted to the right;
p < 0.0001 against the control curve) when challenged with
glibenclamide (3 μM) and was only mediated from 3 mg/ml
to 30 mg/ml. The EC50 for this response was 7.3 mg/ml
(6.4–8.3, n � 3, Figure 2).
Some standard drugs, such as cromakalim and verapamil, were also tested for comparison with the extract.
Cromakalim, 0.01–1 μM, suppressed the rhythmic baseline
contractions of the jejunum (Figure 3) with EC50 of 0.23 μM
(0.11–0.47, n � 5). Cromakalim was also cumulatively administered on K+ 80 mM. It inhibited these contractions
from 0.1 μM to 10 μM. The EC50 was 7.4 μM (3.6–15.0, n � 5).
In comparison, when cromakalim was administered upon
K+ 25 mM contractions (Figure 3), the relaxant eﬀect came
from 0.01 μM to 0.1 μM. The EC50 for this was 0.03 μM
(0.02–0.05, n � 4, p < 0.0001 when matched with the K+
80 mM eﬀect), and this was shifted to the right/blocked
(eﬀect from 0.3 μM to 10 μM, EC50 of 7.3 μM (2.1–25.6,
n � 3) when challenged with glibenclamide (3 μM, p < 0.0001
compared to the control eﬀect).
Verapamil showed its relaxant eﬀect on jejunum baseline
contractions from 0.01 μM 1 μM. The EC50 for this eﬀect was
0.25 μM (0.20–0.30, n � 7, Figure 3). Verapamil’s eﬀect on
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high and low K+-induced contractions (Figure 3) was
exhibited at a similar range of concentrations (p > 0.05),
from 0.01–0.3 μM. The EC50 value for eﬀect on K+ 80 mM
was 0.05 μM (0.04–0.06, n � 7), and the eﬀect on K+ 25 mM
was the same at 0.05 μM (0.04–0.06, n � 10).
3.2. Guinea Pig Ileum. Ga.Cr did not show any stimulant
eﬀect on the ileal quiescent tone up to a concentration of
10 mg/ml (n � 3, data not shown). On the contrary, Ga.Cr
exhibited a mild and partial relaxant eﬀect (3–30 mg/ml,
n � 3) on K+- (80 mM) sustained spasmogenicity (Figure 1).
This eﬀect had the same potency and eﬃcacy shown by
Ga.Cr in rabbit jejunum (p > 0.05). Because of this, further
testing was done only in rabbit jejunum rather than both
tissue preparations.
3.3. Endothelium-Intact Rat Aorta. Ga.Cr did not show any
stimulant eﬀect (n � 3, data not shown) on the default
quiescent tone of the aorta. Later, contractions were induced
by PE (1 μM) in the aorta, which the extract, in increasing
concentrations of 0.3–10 mg/ml, relaxed. The EC50 for this
relaxant eﬀect was 3.9 mg/ml (3.0–4.9, n � 4, Figure 4). This
vasorelaxant action of the extract was repeated in tissues
pretreated with the blocker L-NAME (Figure 4). This impacted the extract’s vasodilator action as seen by the
switching of the concentration-response eﬀect (p < 0.0001
from control curve). The vasodilator action of extract in the
presence of the blocker was mediated from 3 mg/ml to
30 mg/ml, while the EC50 for this was 8.7 mg/ml (8.0–9.4,
n � 4, Figure 4).

4. Discussion
Phalsa berries are traditionally known to be beneﬁcial for GI
and cardiovascular ailments [1–3]. For this reason, a study
was planned to investigate if there is any scientiﬁc basis for
their use in GI disorders. Our results showed that a 70%
aqueous methanolic crude extract of phalsa fruit concentration-dependently relaxed the spontaneous contractions of
isolated rabbit jejunum tissues (Figure 1). The rabbit jejunum contracts in a spontaneous manner when stabilized and
immersed in a physiologic salt solution under a controlled
environment. This makes it useful in testing for potential GI
spasmolytic agents [16, 22]. The crude extract was also tested
on ileal preparations. Guinea pig ileum behaves very differently from the rabbit jejunum in the sense that it does not
exhibit spontaneous contractions. This means that the
guinea pig ileum is not the ideal tissue to test initially for
spasmolytic agents (unless a standard agonist is used) but
rather a good tool to test for the presence of spasmogenic
characteristics [22]. Ga.Cr extract did not show any spasmogenic activity, further strengthening the result acquired
in rabbit jejunum.
To characterize this spasmolytic activity of Ga.Cr extract,
spasmogenicity was induced by K+ 80 mM in jejunum and
ileum tissues. The extract was able to concentration-dependently relax; to a certain extent, these induced contractions in the jejunum and ileum preparations (Figure 1).
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Figure 1: The graphs presenting the activity of Grewia asiatica 70% methanolic extract (Ga.Cr) on isolated intestinal smooth muscle
preparations. The graph on the top shows the eﬀect of Ga.Cr upon baseline rabbit jejunum spasmogenicity. The relaxant activity depicted is
the percent of spontaneous contractions of the tissue (results are mean ± SEM for 7 observations). The graph at the bottom shows activity of
the extract on high K+ (80 mM) spasmogenicity in jejunal and ileal preparations. The spasmolytic behaviour of Ga.Cr is % of agonistsustained spasmogenicity (results are mean ± SEM for 3 observations).

This eﬀect was seen only at higher concentrations in both
the tissues (3–30 mg/ml), and the extract was unable to
completely abolish the induced contractions. The extract
reduced K+ 80 mM contraction in the jejunum to 40 ± 7.6%
and in the ileum to 36.7 ± 2.4% of K+ maximum contraction. It was clear from this ﬁnding that the extract was
unable to completely suppress K+ contractions. As the
extract was equipotent in its response in the jejunum and
ileum, only the jejunum tissue was selected for further
testing.
To further research this spasmolytic action, Ga.Cr was
administered on K+ (25 mM) spasmogenicity in rabbit jejunum. A suppression of K+ (80 mM) contractions normally
indicates a Ca2+ channel blocking eﬀect (CCB), while speciﬁc suppression of K+ (25 mM) contractions indicates a K+
channel opening (KCO) eﬀect [18, 23]. The extract

concentration-dependently completely relaxed these
25 mM contractions indicating that it can fully suppress
K+ (25 mM) but not K+- (80 mM) induced contractions
(Figure 2). This pointed towards a possible speciﬁc KCOlike eﬀect from Ga.Cr extract. Smooth muscle relaxation
via a KCO-like mechanism is known to cause increased K+
exit, which leads to membrane hyperpolarization, reduced
Ca2+ inside the cells, and thus the relaxation of smooth
muscles [24, 25]. To conﬁrm this KCO-like eﬀect, Ga.Cr
response was obtained in tissues pretreated with a standard potassium channel antagonist/blocker (KCB), glibenclamide, which is partially adenosine triphosphate(ATP-) dependent KCB [26]. Glibenclamide inhibited the
spasmolytic action of Ga.Cr, evident from the rightward
shift of the concentration-response curve in rabbit jejunum (Figure 2).

Evidence-Based Complementary and Alternative Medicine

5

100

% of Control

80

60

40

20

0
0.1

1
10
[Ga.Cr] mg/ml

100

K+ (80 mM)
K+ (25 mM)
K+ (25 mM) + Glib

Figure 2: The graph showing how Grewia asiatica 70% methanolic extract (Ga.Cr) suppresses the spasmogenicity of K+ 80 mM and 25 mM
(with and without the standard antagonist glibenclamide or glib 3 μM) on jejunal tissues of a rabbit. Spasmolytic action of Ga.Cr is the
percent of K+-induced contraction (results are mean ± SEM for 3 observations).

The GI smooth muscle relaxant eﬀect of the extract,
possibly mediated via a speciﬁc KCO mechanism, was also
compared to two standard smooth relaxants, namely, cromakalim and verapamil. Cromakalim is an ATP-sensitive
KCO [27] that causes membrane hyperpolarization and
muscle relaxation. Verapamil is a CCB that exhibits its
smooth muscle relaxant eﬀect via reduced intracellular Ca2+
[28]. Being standard spasmolytics, both the agents suppressed the spontaneous contractions of rabbit jejunum
(Figure 3). Both cromakalim and verapamil also inhibited
the induced contractions from both strengths of K+ (25 mM
and 80 mM, Figure 3). Of interest is that, similar to Ga.Cr
extract, cromakalim, being a KCO, was more speciﬁc in
blocking 25 mM concentration-induced contractions than
the 80 mM contractions. This more potent eﬀect on the K+(25 mM) induced contractions, similar to the extract, was
blocked when the tissues were pretreated with glibenclamide, the KCB. Verapamil, on the other hand, inhibited both
25 mM and 80 mM K+-induced contractions equipotently.
These experiments with the standard drugs clearly diﬀerentiated a predominant KCO-like eﬀect from that of a CCB
mechanism. This also conﬁrms our ﬁnding that Ga.Cr extract mediated its GI smooth muscle relaxant eﬀect via a
mixture of KCO and CCB mechanisms with the extract
being more speciﬁc in the KCO eﬀect. This is why it is more
evident in the lower concentration, while the CCB eﬀect is
visible in the higher concentrations.
Diﬀerent studies have been performed on the Grewia
asiatica fruit to investigate its chemistry. Reports have
shown that the fruit contains phenolic compounds such as
ﬂavonoids, carbohydrates, proteins and amino acids, tannins, vitamin C, ﬁxed oils, and steroids [3, 15, 29]. From
among the class of ﬂavonoid compounds, a number of
compounds have been isolated and identiﬁed. Some of these

are isovitexin, luteolin, nepetin, narirutin, hesperetin, catechin, epigallocatechin, kaempferol, myricetin, quercetin
[3, 14, 30], and vitexin [30]. Out of these ﬂavonoids,
quercetin, luteolin [31, 32], and catechin [33] have been
reported to have a CCB activity. This shows that the CCB
activity seen with Ga.Cr can possibly be attributed to these
chemicals in the phalsa fruit. As for the KCO eﬀect seen with
Ga.Cr, this can most possibly be due to the presence of
vitexin in the phalsa fruit. Vitexin is an apigenin ﬂavone
glucoside. Similar to Ga.Cr extract, vitexin has been shown
to suppress rabbit jejunum contractility in isolated tissues
and exhibit glibenclamide-sensitive relaxation of K+
(25 mM) contractions while unable to inhibit K+ 80 mM
contractility [34].
The next round of experiments was conducted on rat
aorta to investigate the eﬀect of Ga.Cr on vascular tissues,
particularly on vascular resistance. Ga.Cr did not exhibit any
constrictor action on the quiescent tone of rat aorta. Once
administered on PE-induced contractions, the extract
showed concentration-dependent relaxation from 0.3 mg/ml
to 10 mg/ml (Figure 4). The vasoconstrictor PE is known to
facilitate the entry of Ca2+ into the vascular cells through the
opening of the receptor-operated Ca2+ channel [35]. The rat
aorta tissues used in the experiments had intact endothelium. This meant that we could test the involvement of the
vasodilator nitric oxide (NO) which is released from the
vascular endothelium and is responsible for the regulation of
vascular tone [20, 21]. To know if the vasorelaxant action of
the extract came about via NO release, the aorta preparations
were challenged with L-NAME, a NO synthase blocker [36].
Once the blocker L-NAME was left with the tissues, it ensured that there is no NO synthesis and thus no NO-mediated vascular relaxation. Doing so showed the partial
blockade of Ga.Cr extract-elicited vasodilation. This is
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Figure 3: The graphs representing the activity of diﬀerent standard spasmolytic agents on isolated rabbit jejunum tissue preparations. The
graph on the top shows the eﬀect of increasing concentrations of cromakalim upon resting baseline, K+ (80 mM) and K+ (25 mM)
spasmogenicity, and K+ (25 mM) with and without the standard antagonist glibenclamide 3 μM (glib) (results are mean ± SEM for 3–5
observations). The bottom graph showing the eﬀect of verapamil on the resting spontaneous baseline, K+ (80 mM), and K+ (25 mM)
spasmogenicity (results are mean ± SEM for 7–10 observations).
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Figure 4: The graph showing the vasodilator eﬀect of Grewia asiatica 70% methanolic extract (Ga.Cr) on isolated endothelium-intact rat
aorta tissue preparation, with and without L-NG-nitro arginine methyl ester 0.1 mM (L-NAME). The vasorelaxant eﬀect was quantiﬁed
upon phenylephrine 1 μM (PE) spasmogenicity. The vasorelaxant action of the extract was determined as a percent of PE-induced
contractions (results are mean ± SEM for 4 observations).

evident from the rightward shift of concentration-response
curves of Ga.Cr extract in Figure 4. This indicated involvement of NO release in the vasodilator action of Ga.Cr.

5. Conclusion
The results from this study showed spasmolytic activity of
70% methanol extract of Grewia asiatica. This eﬀect was
elucidated in isolated small intestinal GI smooth muscle
tissues. Ga.Cr medicated this eﬀect through a mixture of
KCO and CCB mechanisms, although the extract was more
speciﬁc for the former than the latter mechanism of action.
Ga.Cr also showed vasodilator activity in endothelium-intact rat aorta tissue preparations. Ga.Cr exhibited this action
possibly via NO released from vascular endothelium. These
results justify the use of Grewia asiatica fruit in disorders of
the GI and cardiovascular systems. Further studies are
needed to run in vivo animal tests and to isolate the pure
chemicals from this plant that are responsible for the
abovesaid actions.
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